医中誌リンクサービス


文献リスト

1) Jono S, Mckee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000; 87: E10
PubMed
医中誌リンクサービス
2) National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003; 42: S1
PubMed
医中誌リンクサービス
3) 日本透析医学会, 編. 透析患者における二次性副甲状腺機能亢進症治療ガイドライン. 2006
医中誌リンクサービス
4) Guerin AP, London GM, Marchais SJ, et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000; 15: 1014
PubMed CrossRef
医中誌リンクサービス
5) Chertow GM, Burke SK, Paggi P, et al. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int. 2002; 62: 245
PubMed CrossRef
医中誌リンクサービス
6) Koiwa F, Onoda N, Kato H, et al. Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan. Ther Apher Dial. 2005; 9: 340
医学中央雑誌刊行会  PubMed CrossRef
医中誌リンクサービス
7) Iwasaki Y, Takami H, Tani M, et al. Efficency of combined sevelamer and calcium carbonate therapy for hyperphosphatemia in Japanese hemodialysis patients. Ther Apher Dial. 2005; 9: 347
医学中央雑誌刊行会  PubMed CrossRef
医中誌リンクサービス
8) Block GA, Raggi P, Bellasi A, et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney International. 2007; 71: 438
PubMed CrossRef
医中誌リンクサービス
9) Sigematsu T. The Lanthanum Carbonate Reseach Group. Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis. Ther Apher Dial. 2008; 12: 55
医学中央雑誌刊行会  PubMed CrossRef
医中誌リンクサービス
10) Shigematsu T. Lanthanum Carbonate Group. Multicenter prospective randomized, double-blind comparative study between lanthanum carbonate and calcium carbonate as phosphate binders in Japanese hemodialysis patients with hyperphosphatemia. Clin Nephrol. 2008; 70: 404
PubMed
医中誌リンクサービス
11) DʼHaese PC, Spasovski GB, Sikole A, et al. A multicenter study on the effects of lanthanum carbonate(Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int Suppl. 2003; 85: S73
PubMed
医中誌リンクサービス
12) Wilson R, Zhang P, Smyth M, et al. Assessment of survival in a 2-year comparative study of lanthanum carbonate versus standard therapy. Curr Med Res Opin. 2009; 25: 3021
PubMed CrossRef
医中誌リンクサービス
13) Shigematsu T, Lanthanum Carbonate Group. Three-year extension study of lanthanum carbonate therapy in Japanese hemodialysis patients. Clin Exp Nephrol. 2010. Sep 4[Epub ahead of print]
医中誌リンクサービス
14) Isakova T, Gutiérrez OM, Smith K, et al. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrol Dial Transplant. 2010. Jul 14[Epub ahead of print]
医中誌リンクサービス


NPO医学中央雑誌刊行会
https://www.jamas.or.jp/
info@jamas.or.jp